BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 28850267)

  • 1. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice.
    Kornete M; Sgouroudis E; Piccirillo CA
    J Immunol; 2012 Feb; 188(3):1064-74. PubMed ID: 22227569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
    Brode S; Raine T; Zaccone P; Cooke A
    J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
    Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
    Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis.
    Tauro S; Nguyen P; Li B; Geiger TL
    Eur J Immunol; 2013 May; 43(5):1195-207. PubMed ID: 23436224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and enrichment of mouse insulin-specific CD4
    Đedović N; Paunović V; Stojanović I
    J Immunol Methods; 2019 Jul; 470():46-54. PubMed ID: 31039339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes.
    Kornete M; Piccirillo CA
    Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
    Kaminitz A; Mizrahi K; Askenasy N
    Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
    Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
    Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
    Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
    Shao TY; Hsu LH; Chien CH; Chiang BL
    Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 cells in type 1 diabetes.
    Shao S; He F; Yang Y; Yuan G; Zhang M; Yu X
    Cell Immunol; 2012 Nov; 280(1):16-21. PubMed ID: 23246831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice.
    Hawiger D; Tran E; Du W; Booth CJ; Wen L; Dong C; Flavell RA
    J Immunol; 2008 Mar; 180(5):3140-7. PubMed ID: 18292537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.